Pharmaceutical APIs
Empagliflozin
Active Pharmaceutical Ingredient — Neurology
Empagliflozin is an SGLT2 inhibitor used to treat type-2 diabetes by reducing renal glucose reabsorption and promoting urinary glucose excretion.
- CAS Number
- 864070-44-0
- Therapeutic Area
- Neurology
- Drug Class
- Antidiabetics
- Molecular Formula
- C23H27ClO7
- Molecular Weight
- 450.91
- PubChem CID
- 11949646
RFQ / Inquiry
Request Empagliflozin
Send a structured RFQ to APINEXA's coordination team — confidential, supplier-matched, audit-grade. Typical response in 24 business hours.